Navigation Links
Onyx Pharmaceuticals Announces First Quarter 2011 Financial Results Teleconference and Webcast
Date:4/21/2011

SAN FRANCISCO, April 21, 2011 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will host a webcast and teleconference with management to discuss first quarter 2011 financial results, as well as provide a general business overview on Wednesday, May 4, 2011, at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time; 2:00 p.m. Central European Time).  Financial results for the first quarter ended March 31, 2011 will be released earlier that day.

Interested parties may access a live webcast of the presentation on the company's website at: http://www.onyx-pharm.com/investors/event-calendarWithin the U.S.:

888-771-4371International:

847-585-4405Passcode:

29609004#A replay of the presentation will be available on the Onyx website or by dialing:Dial in:

630-652-3042 Passcode:

29609004# (approximately one hour after the teleconference concludes)  The replay will be available through May 18, 2011. About Onyx Pharmaceuticals, Inc.Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals Inc., is developing and marketing Nexavar® (sorafenib) tablets, a small molecule drug that is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in a variety of tumor types. Beyond Nexavar, Onyx has established a development pipeline of anticancer compounds at various stages of clinical testing, including carfilzomib, a selective proteasome inhibitor, that is currently being evaluated in multiple clinical trials for the treatment of patients with relapsed or relapsed/refractory multiple myeloma in various settings and solid tumors. ONX 0801,
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2011 Financial Results
2. Fleming Pharmaceuticals Now Ready to Step Up Production of Nuclear Radiation Safeguard, ThyroShield®
3. Marinus Pharmaceuticals Announces Commencement of Phase 2 Trial of Ganaxolone for the Treatment of Posttraumatic Stress Disorder
4. Hanmi Pharmaceuticals to Acquire the Rights for a Promising Phase II Anti-cancer Src Kinase/Pretubulin Dual Inhibitor from Kinex Pharmaceuticals, in Selected Asian Territories
5. Merrimack Pharmaceuticals Announces that Recruitment is Open in a Phase 1 Combination Study of MM-111 with Multiple Treatment Regimens in HER2 Positive Patients
6. Valeant Pharmaceuticals Announces Redemption of 4.0% Convertible Subordinated Notes Due 2013
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 36th Annual Health Care Conference
8. Sagent Pharmaceuticals Upsizes and Prices Initial Public Offering
9. Amira Pharmaceuticals Receives Orphan Drug Status for a Novel LPA1 Antagonist, AM152, for the Treatment of Idiopathic Pulmonary Fibrosis
10. Cumberland Pharmaceuticals Announces New Product Addition With Hepatoren™ (ifetroban) Injection
11. Bexion Pharmaceuticals Receives Outstanding Biotech Innovation Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... 2015  PARI Respiratory Equipment has won a 2015 American ... approved by the FDA on December 2, is the first ... PLUS ® Nebulizer for patients with cystic fibrosis. ... put into this unique product offering of nebulized drug and ... to use, we also wanted to convey that the components ...
(Date:6/3/2015)... LONDON , June 3, 2015 ... clinical gaps in the market, says  GBI Research ... provider GBI Research - Acute Myeloid Leukemia Therapeutics Market ... AML therapeutics market to increase moderately from $632.6 million in ... Growth Rate (CAGR) of 4.8%. Several drugs to ...
(Date:6/3/2015)... 3, 2015  Varian Medical Systems (NYSE: VAR ), world ... cancer, is expanding in the Middle East ... Saudi Arabia . Varian Medical Systems Arabia, the ... was officially launched today at a ceremony attended by local ... "This move represents the next step in our commitment ...
Breaking Medicine Technology:Kitabis Pak Wins American Package Design Award 2Novel Acute Myeloid Leukemia Therapies to Offer Clinical Benefit in Small Patient Cohorts 2Novel Acute Myeloid Leukemia Therapies to Offer Clinical Benefit in Small Patient Cohorts 3Varian Establishes Local Entity in Saudi Arabia to Support Expansion in Middle East 2
(Date:6/3/2015)... Baltimore, MD (PRWEB) June 03, 2015 On ... be a $13 billion industry by 2020 ( click here ... and Markets), computer scientists believe Baltimore has the ... fast-growing industry in which genetic code and other biological data ... and cure disease. “Baltimore contains all the elements of ...
(Date:6/3/2015)... Alberto Grignolo, PhD, will be honored ... Meeting. DIA’s Global Inspire Award program recognizes the organization’s ... commitment to service on a global scale. ... annually recognizes one DIA member for meritorious service through ... DIA to foster innovation to improve health and well-being ...
(Date:6/3/2015)... CT (PRWEB) June 03, 2015 Z-Medica®, ... announces today since June has been designated as National ... commends the Tucson, AZ. Police Department for its commitment ... its personnel utilized their Individual First Aid Kits (IFAK) ... civilians involved in shootings, stabbings or traffic accidents. Each ...
(Date:6/3/2015)... 03, 2015 Sitting at a computer ... in the back, neck, shoulders and/or wrists. This can ... In addition, recent research links sitting for long periods ... diseases. Fortunately, three inventors from Oakville, Ontario, are offering ... desk. , They have developed a prototype for a ...
(Date:6/3/2015)... Implant design can have a profound ... unites bone to an implant surface. The unique triangular-shape ... to encourage bone regeneration, resulting in the gain of ... soft tissues for more esthetic restorations. , “It’s all ... MIS Implants. The triangular neck of the V3 provides ...
Breaking Medicine News(10 mins):Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 3Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 2Health News:Longtime DIA Champion and PAREXEL Executive Honored with Global Inspire Award at DIA’s Annual Meeting 3Health News:Z-Medica Commends Tucson Police Department for Trauma Kit Utilization 2Health News:Adjustable Height Tabletop Unit Invented by Three InventHelp® Clients (TOR-9278) 2Health News:MIS Implants Launches Radically New V3 Dental Implant For Immediate Biological Benefits 2
... Glucotrace (Fluorodeoxyglucose) for Use in Earlier, ... FLEURUS, Belgium, May 28 /PRNewswire-FirstCall/ - MDS Nordion, ... radiopharmaceuticals used in molecular medicine, today announced the ... the production of Glucotrace (Fluorodeoxyglucose), a radiopharmaceutical used ...
... results beyond soothing of infants, , , WEDNESDAY, May 27 ... and encourage feeding in premature infants, University of Alberta ... neonatal units across North America, but how beneficial it ... Dr. Manoj Kumar, an assistant clinical professor in the ...
... The Lance Armstrong Foundation (LAF) and Penn ... develop and disseminate the LIVESTRONG Care Plan Powered ... cancer survivors, their families and physicians the ability ... up-to-date treatment information based on Institute of Medicine ...
... HARRISBURG, Pa., May 27 Secretary of Public Welfare ... Smart Pharmacy initiative, saying the plan would save taxpayers ... the pharmacy initiative for providers. "The savings from the ... Richman. "This is not a drill. Pennsylvania is facing ...
... ROCHESTER, Minn. -- Researchers have discovered a novel molecular path ... that mainly affects women and slowly destroys their livers. Primary ... because it is a first step toward developing a targeted ... 11, 2009, issue of the New England Journal ...
... co-sponsored by W.K. Kellogg Foundation WASHINGTON, May 27 ... Friedman School of Nutrition Science & Policy will present ... on the most pressing nutrition and health policy issues ... join academic, corporate and government colleagues for an in-depth ...
Cached Medicine News:Health News:MDS Nordion Opens New Radiopharmaceutical Production Facility in Belgium 2Health News:Music May Temper Pain in Preemies 2Health News:Music May Temper Pain in Preemies 3Health News:LIVESTRONG and Penn Medicine announce partnership to bring online care plan tool to cancer survivors 2Health News:Secretary of Public Welfare Corrects the Record on 'Smart Pharmacy' Initiative 2Health News:Mayo researchers help discover genetic cause for primary biliary cirrhosis 2Health News:Mayo researchers help discover genetic cause for primary biliary cirrhosis 3Health News:Tufts University Friedman School of Nutrition Presents National Forum: 'Children's Health: The Future of Food & Nutrition Policy' 2
Fortitude as a unique complement to the spinal concepts family of products....
... implant made of radiolucent carbon fiber ... has a modulus of elasticity approximating ... is an implant that meets the ... while optimizing the fusion environment through ...
... Spinal Implant system. Material that has a ... bone. The result is an implant that ... support, while optimizing the fusion environment through ... anatomic design with 5 and 10 degrees ...
Caspar cervical retractor (lamina spreader), counter-retractor complete with 5 blades and forceps. Height: max. 165 mm, Maximal spread: 85 mm...
Medicine Products: